世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

血管形成術用バルーンの市場規模、シェア、動向分析レポート:タイプ別(ノーマル、DEB、カッティング、スコアリング)、用途別(末梢、冠動脈)、最終用途別(病院、ASC、カテラボ)、地域別、およびセグメント別予測、2023年~2030年


Angioplasty Balloons Market Size, Share & Trends Analysis Report By Type (Normal, DEB, Cutting, Scoring), By Application (Peripheral, Coronary), By End-use (Hospitals, ASCs, Cath Labs), By Region, And Segment Forecasts, 2023 - 2030

血管形成術用バルーン市場の成長と動向 Grand View Research, Inc.の最新レポートによると、血管形成術用バルーンの世界市場規模は、2023年から2030年にかけて年平均成長率3.9%を記録し、2030年には32.4億ドル... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2023年10月23日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
120 英語

本レポートは受注生産のため、ご納品のお時間をいただく場合がございます。


 

サマリー

血管形成術用バルーン市場の成長と動向

Grand View Research, Inc.の最新レポートによると、血管形成術用バルーンの世界市場規模は、2023年から2030年にかけて年平均成長率3.9%を記録し、2030年には32.4億ドルに達する見込みです。この成長は、有利な政府政策と冠動脈および末梢インターベンションの増加によるものである。血管形成術は低侵襲の手技であるため、患者や外科医は高コストのステント留置よりもこの手技を好む。さらに、血管形成術用バルーンの進歩や地理的範囲の拡大が、今後数年間の市場成長を促進する可能性が高い。

例えば、2014年12月、Medtronic plcは末梢動脈疾患治療用の薬剤コーティングバルーンIN.PACT AdmiralのFDA承認を取得した。また、同社は日本の厚生労働省から上肢末梢動脈疾患の治療薬として製品承認を取得している。TREK、MINI TREK、AngioSculpt、Flextomeといったカッティング・バルーンやスコアリング・バルーンが承認・商品化され、新しいバルーンの採用が増加していることも、市場をさらに牽引するとみられる。

血管形成術用バルーン市場レポート ハイライト

- 2022年の血管形成術用バルーン市場は、低価格と冠動脈閉塞の治療能力により、通常型バルーンが54.2%のシェアを獲得し、市場を牽引

- DEBは再狭窄率の低下と大手企業による研究開発投資の増加により、予測期間中に最も急成長するセグメントと予測される

- 冠動脈セグメントは、すべての心臓疾患の中で最も一般的な冠動脈疾患の発生率が高いため、2022年には54.1%のシェアで市場をリードする

- ASCsセグメントは2022年に51.8%の最大シェアを占め、2030年までのCAGRは4.1%と予測される。

- 北米は2022年に39.6%と最大の収益シェアを占め、大手企業の存在により予測期間中もその地位を維持すると予想される。

ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Angioplasty Balloons Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Angioplasty Balloons Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Angioplasty Balloons Market: Type Estimates & Trend Analysis
4.1. Angioplasty Balloons Market: Key Takeaways
4.2. Angioplasty Balloons Market: Type Movement & Market Share Analysis, 2022 & 2030
4.3. Normal Balloons
4.3.1. Normal balloons market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Drug Eluting Balloons
4.4.1. Drug eluting balloons market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Cutting Balloons
4.5.1. Cutting balloons market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Scoring Balloons
4.6.1. Scoring balloons market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Angioplasty Balloons Market: Application Estimates & Trend Analysis
5.1. Angioplasty Balloons Market: Key Takeaways
5.2. Angioplasty Balloons Market: Application Movement & Market Share Analysis, 2022 & 2030
5.3. Peripheral
5.3.1. Peripheral market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Coronary
5.4.1. Coronary market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Angioplasty Balloons Market: End-use Estimates & Trend Analysis
6.1. Angioplasty Balloons Market: Key Takeaways
6.2. Angioplasty Balloons Market: End-use Movement & Market Share Analysis, 2022 & 2030
6.3. ASCs
6.3.1. ASCs market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Cath Labs
6.5.1. Cath labs market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Angioplasty Balloons Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Angioplasty Balloons Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Sweden
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Norway
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Denmark
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. Saudi Arabia
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. South Africa
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Medtronic
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Boston Scientific Corporation
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Johnson & Johnson Services, Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Abbott
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. C. R. Bard, Inc.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Spectranetics
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Terumo Medical Corporation
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Cardinal Health
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. BIOTRONIK
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Cook
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. ENDOCOR GmbH
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. B. Braun Melsungen AG
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives

 

ページTOPに戻る


 

Summary

Angioplasty Balloons Market Growth & Trends

The global angioplasty balloons market size is expected to reach USD 3.24 billion by 2030, registering a CAGR of 3.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. This growth is attributed to favorable government policies and increasing coronary and peripheral interventions. Angioplasty is a minimally invasive procedure, hence patients and surgeons prefer this procedure over high-cost stent placements. Furthermore, advancements in angioplasty balloons and expanding geographical reach are likely to propel the market growth in the coming years.

For instance, in December 2014, Medtronic plc received an FDA approval for their drug-coated balloon IN.PACT Admiral for the treatment of peripheral artery disease. The company also received product approval from Japanese Ministry of Health, Labor and Welfare for the treatment of peripheral artery disease in the upper leg. Approval and commercialization of cutting and scoring balloons, such as TREK and MINI TREK, AngioSculpt, and Flextome balloons along with rising adoption of new balloons are likely to drive the market further.

Angioplasty Balloons Market Report Highlights

• The normal balloons segment led the market in 2022 with a share of 54.2% due to low costs and ability of these products to treat coronary artery obstruction

• DEBs are anticipated to be the fastest-growing segment during the forecast period due to lower restenosis rate and increased R&D investments by major companies

• The coronary segment led the market with a share of 54.1% in 2022 due to the high incidence of coronary artery diseases, which are the most common type of all heart diseases

• The ASCs segment accounted for the largest share of 51.8% in 2022 and is also projected to advance at the highest CAGR of 4.1% through 2030, due to the huge demand for treatments in these settings.

• North America accounted for the maximum revenue share of 39.6% in 2022 and is expected to maintain its position during the forecast period due to the presence of major companies



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Angioplasty Balloons Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Angioplasty Balloons Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Angioplasty Balloons Market: Type Estimates & Trend Analysis
4.1. Angioplasty Balloons Market: Key Takeaways
4.2. Angioplasty Balloons Market: Type Movement & Market Share Analysis, 2022 & 2030
4.3. Normal Balloons
4.3.1. Normal balloons market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Drug Eluting Balloons
4.4.1. Drug eluting balloons market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Cutting Balloons
4.5.1. Cutting balloons market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Scoring Balloons
4.6.1. Scoring balloons market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Angioplasty Balloons Market: Application Estimates & Trend Analysis
5.1. Angioplasty Balloons Market: Key Takeaways
5.2. Angioplasty Balloons Market: Application Movement & Market Share Analysis, 2022 & 2030
5.3. Peripheral
5.3.1. Peripheral market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Coronary
5.4.1. Coronary market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Angioplasty Balloons Market: End-use Estimates & Trend Analysis
6.1. Angioplasty Balloons Market: Key Takeaways
6.2. Angioplasty Balloons Market: End-use Movement & Market Share Analysis, 2022 & 2030
6.3. ASCs
6.3.1. ASCs market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Cath Labs
6.5.1. Cath labs market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Angioplasty Balloons Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Angioplasty Balloons Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Sweden
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Norway
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Denmark
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. Saudi Arabia
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. South Africa
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Medtronic
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Boston Scientific Corporation
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Johnson & Johnson Services, Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Abbott
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. C. R. Bard, Inc.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Spectranetics
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Terumo Medical Corporation
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Cardinal Health
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. BIOTRONIK
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Cook
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. ENDOCOR GmbH
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. B. Braun Melsungen AG
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

Grand View Research社の医療機器分野での最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る